Coronary heart disease risk factors in women with polycystic ovary syndrome.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Arteriosclerosis, Thrombosis and Vascular Biology

• Publication date

  1995-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.ATV.15.7.821PMID 7600112
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Endocrine consequences of weight loss in obese, hyperandrogenic, anovulatory women.

  1994cited by this paper
• Hyperinsulinaemia, obesity, and syndrome X

  1994cited by this paper
• Evidence for a single gene effect causing polycystic ovaries and male pattern baldness.

  1993cited by this paper
• Evidence for a single gene effect causing polycystic ovaries and male pattern baldness

  1993cited by this paper
• Lipid and apolipoprotein abnormalities in hirsute women. I. The association with insulin resistance

  1992cited by this paper
• Lipid and apolipoprotein abnormalities in hirsute women: I. The association with insulin resistance

  1992cited by this paper
• Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones.

  1992cited by this paper
• Polycystic ovary syndrome and risk for myocardial infarction: Evaluated from a risk factor model based on a prospective population study of women

  1992cited by this paper
• The role of hyperinsulinemia in the development of lipid disturbances in nonobese and obese women with the polycystic ovary syndrome

  1991cited by this paper
• 5 alpha-reductase and polycystic ovaries.

  1990cited by this paper
• 5 α-reductase activity in polycystic ovary syndrome

  1990cited by this paper
• 5 alpha-reductase activity in polycystic ovary syndrome.

  1990cited by this paper
• 5α-reductase and polycystic ovaries

  1990cited by this paper
• Clinical signs of androgen excess as risk factors for coronary artery disease.

  1990cited by this paper
• Is baldness a risk factor for coronary artery disease? A review of the literature.

  1990cited by this paper
• Familial clustering in the polycystic ovarian syndrome.

  1989cited by this paper
• Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome.

  1989cited by this paper
• The polycystic ovary syndrome: pathogenesis and treatment.

  1989cited by this paper
• Banting lecture 1988. Role of insulin resistance in human disease.

  1988cited by this paper
• The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism.

  1988cited by this paper
• Role of Insulin Resistance in Human Disease

  1988cited by this paper
• Hyperinsulinemia in hyperthecosis of the ovaries.

  1986cited by this paper
• Persistence of insulin resistance in polycystic ovarian disease after inhibition of ovarian steroid secretion.

  1986cited by this paper
• Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome.

  1985cited by this paper
• Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure.

  1982cited by this paper
• Enzymatic determination of total serum cholesterol.

  1974cited by this paper
• Quantitative determination of serum triglycerides by the use of enzymes.

  1973cited by this paper
• Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

  1972cited by this paper

• Endothelial Dysfunction in Women and its Relationship with Infertility

  2025cites this paper
• Metabolic, androgenic, and physical activity profiles in women aged over 40 years with polycystic ovary syndrome: A comparative analysis using UK Biobank data

  2025cites this paper
• Atherogenic ApoB-dyslipidemia, atherosclerotic cardiovascular disease, cardiac dysfunction and remodeling in high-risk young women with and without polycystic ovary syndrome: A pilot study

  2025cites this paper
• Understanding Dyslipidemia in Women across their Lifespan: Sex Differences in Lipoprotein Metabolism and Hormonal Influence

  2025cites this paper
• Development and validation of a model to identify polycystic ovary syndrome in the French national administrative health database

  2025cites this paper
• Differences in Prevalence of Polycystic Ovary Syndrome Diagnosis Across Sexual Orientation in a Longitudinal Cohort of U.S. Adults

  2025cites this paper
• Role of Sodium–Glucose Cotransporter-2 Inhibitors in Managing Polycystic Ovary Syndrome: A Systematic Review

  2025cites this paper
• Management of Hypertension in Patients With Polycystic Ovarian Syndrome: A Mini-Review.

  2024cites this paper
• Coronary Artery Disease in Women—Review of Risk Factors and Emerging Concepts

  2024cites this paper
• Association Between Chlamydia trachomatis and Helicobacter pylori with Inflammation in Polycystic Ovary Syndrome: A Cross-Sectional Study

  2024cites this paper
• Associations between hypertension with reproductive and menopausal factors: An integrated women’s health programme (IWHP) study

  2024cites this paper
• Beneficial Effects of Pomegranate Extracts for Benign Gynecologic Disorders

  2024cites this paper
• A Randomized Controlled Trial in Obese Adults with Polycystic Ovarian Syndrome: Examining the Impact of Short-term Integrated Naturopathy and Yoga Interventions on Testosterone, Oxidative Stress, and Mental Health

  2024cites this paper
• Metabolic dysfunctions in polycystic ovary syndrome

  2024cites this paper
• Evaluation of cardiovascular risk marker in patients with polycystic ovary syndrome: Homocysteine

  2024cites this paper
• Etanercept Ameliorates Vascular, Endocrine, and Ovarian Changes in a Rat Model of DHEA-Induced Polycystic Ovary Syndrome

  2023cites this paper
• High density lipoprotein: When to rethink too much of a good thing

  2023cites this paper
• Androgenicity in Young Women and Development of Metabolic Syndrome Before Menopause: The CARDIA and CARDIA Women’s Studies

  2023cites this paper
• Blood Pressure Values in Apparently Healthy Sudanese Population

  2023cites this paper
• Integrated Chinese and Western Medicine for Coronary Heart Disease Prevention in Polycystic Ovary Syndrome: A 19-Year Nationwide Cohort Study

  2023cites this paper
• Relationship between Dry Eye Disease and Dyslipidemia: A Systematic Review

  2023cites this paper
• The relationship between polycystic ovary syndrome and coronary heart disease: a bibliometric analysis

  2023cites this paper
• Association of Demographic, Lipid and Hormonal Profile with Polycystic Ovarian Syndrome in Pakistani Women

  2023cites this paper
• Leptin Gene Polymorphism Rs7799039; G2548A, Metabolic and Oxidative Stress Markers in Polycystic Ovarian Syndrome

  2022cites this paper
• Study of the effect of beta glycan supplemented diet on vascular functions in male rats

  2022cites this paper
• The polycystic ovary syndrome: the first 150 years of study

  2022cites this paper
• Correlation of Serum Homocysteine Levels and Hyperinsulinaemia with Body Mass Index in Polycystic Ovarian Syndrome

  2022cites this paper
• The main directions and prospects in polycystic ovary syndrome treatment

  2021cites this paper
• Assessment of Early Markers of Cardiovascular Risk in Polycystic Ovary Syndrome.

  2021cites this paper
• Profile of Daughters and Sisters of Women with Polycystic Ovary Syndrome: The Role of Proband's Glucose Tolerance.

  2021cites this paper
• Evaluation of relationship among polycystic ovary syndrome, atherogenic index of plasma, and high sensitive C reactive protein

  2021cites this paper
• Women With Polycystic Ovary Syndrome Have an Increased Risk of Major Cardiovascular Events: a Population Study

  2021cites this paper
• Estimation of Blood Pressure, Pulse Rate, Waist Circumference, BMI and BMR among PCOS Individuals

  2021cites this paper
• Impact of Increased Oxidative Stress on Cardiovascular Diseases in Women With Polycystic Ovary Syndrome

  2021cites this paper
• The Role of Stem Cells and Their Derived Extracellular Vesicles in Restoring Female and Male Fertility

  2021cites this paper
• Gender differences in human adrenal cortex and its disorders.

  2021cites this paper
• Role of BMI in PCOS Towards Cardiovascular Risk Factors

  2020cites this paper
• Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis

  2020influential citation
• Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline.

  2020cites this paper
• Effects of Metformin compared to Thiazolidinediones on vascular endothelial function in Polycystic Ovary syndrome: A systematic review

  2020cites this paper
• Clinical Impact of Insulin Resistance in Women with Polycystic Ovary Syndrome

  2020cites this paper
• The effect of parity on exercise physiology in women with heart failure with preserved ejection fraction

  2020cites this paper
• Association Between Methylenetetrahydrofoate Reductase Gene C677T Polymorphism and Susceptibility to Polycystic Ovary Syndrome

  2020cites this paper
• Effect of High Levels of Testosterone on Cardiovascular Risk in Polycystic Ovary Syndrome (PCOS)

  2020cites this paper
• Polycystic Ovary Disease and Obesity: Leptin, Weight-loss Medication, and Bariatric Surgery

  2020cites this paper
• Risk Factors in Young Female Patient with Polycystic Ovary Syndrome presenting with Acute Myocardial Infarction

  2020cites this paper
• Managing Women’s Hyperandrogenism

  2019cites this paper
• Sex Differences in Coronary Artery Disease

  2019cites this paper
• Regional cerebral activation accompanies sympathoexcitation in women with polycystic ovary syndrome.

  2019cites this paper
• Biomarkers of Endothelial Dysfunction in Women With Polycystic Ovary Syndrome

  2019cites this paper
• Definition and Epidemiology

  2019cites this paper
• Mineralocorticoid receptor blockade attenuates disrupted glutathione-dependent antioxidant defense and elevated endoglin in the hearts of pregnant rats exposed to testosterone

  2019cites this paper
• Peroxiredoxin 4 levels in patients with PCOS and/or obesity.

  2019cites this paper
• Polycystic Ovary Syndrome and Hyperandrogenic States

  2019cites this paper
• The Effect of Reproductive Factors on Coronary Artery Disease in Women

  2019cites this paper
• Impact of vitamin D supplementation on cardio-metabolic status and androgen profile in women with polycystic ovary syndrome: placebo-controlled clinical trial

  2019cites this paper
• Prenatal androgen exposure causes hypertension and gut microbiota dysbiosis

  2018cites this paper
• Treatments

  2018cites this paper
• Coronary microvascular dysfunction is not associated with a history of reproductive risk factors in women with angina pectoris-An iPOWER substudy.

  2018cites this paper
• Hypertensive disorders and diabetic pregnancy

  2018cites this paper
• Characteristics of heart rate variability in women with polycystic ovary syndrome

  2018cites this paper
• Childhood cardiovascular health and subfertility: The Bogalusa Heart Study

  2018cites this paper
• The obesogen tributyltin induces features of polycystic ovary syndrome (PCOS): a review

  2018cites this paper
• Increased fibulin-1 plasma levels in polycystic ovary syndrome (PCOS) patients: possible contribution to the link between PCOS and cardiovascular risk

  2018cites this paper
• OXIDATIVE STRESS BIOMARKERS IN POLYCYSTIC OVARY SYNDROME ( PCOS )

  2018cites this paper
• How To Effect Of Metformın Addıng To Cyproterone Acetate + Ethinyl Estradiol Treatment On Antıoxıdant Status In Polycystıc Ovary Syndrome?

  2018cites this paper
• Cardiometabolic risks in PCOS: a review of the current state of knowledge

  2018cites this paper
• The Role of C-Peptide as Marker of Cardiometabolic Risk in Women With Polycystic Ovary Syndrome: A Controlled Study

  2018cites this paper
• Serum lipid profile and insulin resistance in women with polycystic ovary syndrome (PCOS)

  2018cites this paper
• [Long-term consequences of polycystic ovary syndrome].

  2017cites this paper
• Role of insulin sensitising agents in altering PSA level in PCOS

  2017cites this paper
• Dyslipidemia in Women with Polycystic Ovary Syndrome in Khammam District, Telangana, India

  2017cites this paper
• ROLE OF STEROID HORMONES IN POLYCYSTIC OVARIAN SYNDROME (PCOS) IN SOUTH INDIAN WOMEN

  2017cites this paper
• Effect of Electroacupuncture on Anovulation, Epinephrine and Norepinephrine Levels in Drug Induced Polycystic Ovary Rats

  2017cites this paper
• Obese adolescents with polycystic ovarian syndrome have elevated cardiovascular disease risk markers

  2017cites this paper
• Strategies and methods to study female-specific cardiovascular health and disease: a guide for clinical scientists

  2016cites this paper
• The Association between Symptoms of Dry Eye Syndrome and Metabolic Outcome in a General Population in Korea

  2016cites this paper
• Obesity, type 2 diabetes mellitus and cardiovascular disease risk: an uptodate in the management of polycystic ovary syndrome.

  2016cites this paper
• A case–control study on reduced HDL2b in patients with polycystic ovarian syndrome

  2016influential citation
• Cardiovascular Risk Factors: Does Sex Matter?

  2016cites this paper
• Anthropometric and metabolic correlates of sympathetic nervous system activation in women with polycystic ovary syndrome

  2016cites this paper
• Varying patterns of brachial artery flow‐mediated dilatation in women with polycystic ovary syndrome and controls: An application of the group‐based trajectory modeling

  2016cites this paper
• Polycystic Ovarian Syndrome: An awareness guide for women

  2016cites this paper
• Effect of simvastatin and combined oral contraceptive pills in the treatment of polycystic ovary syndrome

  2016cites this paper
• Serum Procalcitonin and Proinflammatory markers in Polycystic Ovary Syndrome

  2016cites this paper
• Testosterone assocition with blood pressure profile and left ventricular mass in a young hypertensive population

  2016cites this paper
• Drug-Induced Hyperglycemia and Diabetes Mellitus

  2016cites this paper
• Effect of Administration of Metformin on Lipid Profile in Patients with Polycystic Ovary Syndrome after Six Months of Treatment

  2016cites this paper
• Lipid Profile in Sudanese Women with Polycystic Ovary Syndrome : A Prospective Case-Control Study Conducted at Gezira State , Central Sudan

  2016cites this paper
• Hyperandrogenism and Polycystic Ovarian Disease: Impact on Vascular System

  2015cites this paper
• Characterisation of microparticles and nitro-oxidative stress in cardiometabolic disease

  2015cites this paper
• Trend of Cardio-Metabolic Risk Factors in Polycystic Ovary Syndrome: A Population-Based Prospective Cohort Study

  2015cites this paper
• Polycystic Ovarian Syndrome in Perimenopausal Women: A Pilot Study

  2015cites this paper
• Polycystic ovarian syndrome.

  2015cites this paper
• A COMPREHENSIVE OVER VIEW OF POLYCYSTIC OVARIAN SYNDROME ( PCOS )

  2015cites this paper
• Relation of elevated androgen to lipid profile in patients with polycystic ovary syndrome

  2015cites this paper
• ESTIMATION OF SERUM HOMOCYSTEINE LEVEL IN WOMEN WITH POLYCYSTIC OVARIAN SYNDROME (PCOS) - A CASE CONTROL STUDY.

  2015cites this paper
• Metabolic syndrome through the female life cycle

  2015cites this paper
• Polycystic Ovarian Syndrome and its Relationship with Cardiovascular Disease

  2015cites this paper
• Le syndrome des ovaires polykystiques chez les adolescentes obèses

  2015cites this paper